A Phase 2, Open-Label, Single-Arm, Intra-Subject Dose-Escalation Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimond in Subjects with Symptomatic Moderate or Severe Chronic GVHD...